Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
$1.060M
Current Assets
2025 Q4
Current Liabilities
2025 Q4
Current Ratio
2025 Q4
0.09%
Total Assets
2025 Q4
Total Liabilities
2025 Q4
Book Value
2025 Q4
$8.041M
Cash
2025 Q4
P/E
TTM
128.5
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $136.15 Million

About Aimei Health Technology Co Ltd

Aimei Health Technology Co Ltd (NASDAQ: AFJK) is a blank check special purpose acquisition company incorporated to identify and complete a business combination with one or more target businesses. The company raised capital through an IPO completed in December 2023, with proceeds held in a trust account administered by Continental Stock Transfer & Trust Company. AFJK targets late-stage development or revenue-generating businesses with high growth prospects, experienced management teams, and sustainable proprietary positions, with a stated focus on companies connected to China or Chinese-American markets. As of the filing date of its 10-K (filed 2026-05-04), the company had entered into a Business Combination Agreement with United Hydrogen and related entities but had not yet closed the transaction. The company carries material regulatory risk tied to potential PRC government oversight of its business combination, including possible CSRC review requirements.

Revenue model
As a SPAC, AFJK does not generate operating revenue. Capital is held in a trust account following the IPO (December 2023), with a stated redemption value of $10.10 per share. Returns to shareholders depend entirely on the completion of a qualifying business combination.
Products and services
Blank check acquisition vehicle seeking a business combination target. The announced pending target is United Hydrogen, as disclosed in the 10-K filed 2026-05-04.
Customers and end markets
Not applicable. AFJK has no customers or commercial end markets as of the filing date (2026-05-04). Its counterparties are IPO investors and the target company, United Hydrogen.
Value-chain role
SPAC sponsor and acquisition vehicle. AFJK's role is to source, negotiate, and close a merger or acquisition with a private operating company, then facilitate a public listing of the combined entity.
Geographic exposure
Incorporated in a non-PRC jurisdiction but focused on targets with PRC-connected operations. Faces PRC regulatory risks including CSRC and CAC oversight, as disclosed in the 10-K filed 2026-05-04.

Source: SEC 10-K, filed 2026-05-04

Industry: Blank Checks

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support